secwatch.observer — SEC 8-K summary
======================================

Issuer:     CEL SCI CORP (CVM)
CIK:        0000725363
Form:       8-K
Filed at:   2024-07-29T23:59:59+00:00
Accession:  0001654954-24-009564
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CEL-SCI closes $10.8M public offering of common stock and pre-funded warrants
-----------------------------------------------------------------------------

- Gross proceeds of $10,845,000 from offering of 10,845,000 shares/common stock or pre-funded warrants at $1.00/share.
- Net proceeds to fund continued development of lead cancer drug Multikine and for general corporate purposes.
- Offering closed on July 29, 2024; ThinkEquity acted as sole placement agent.
- Officers and directors subject to 90-day lock-up on company securities.
- Pre-funded warrants exercisable at $0.01 per share and expire when fully exercised.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/0001654954-24-009564-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/725363/000165495424009564/cvm_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-009564

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer